ID   PIM3_HUMAN              Reviewed;         326 AA.
AC   Q86V86; A5D8X8; A8K7J0; B1B0P0; Q68BM2;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=Serine/threonine-protein kinase pim-3;
DE            EC=2.7.11.1;
GN   Name=PIM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=15540201; DOI=10.1002/ijc.20719;
RA   Fujii C., Nakamoto Y., Lu P., Tsuneyama K., Popivanova B.K.,
RA   Kaneko S., Mukaida N.;
RT   "Aberrant expression of serine/threonine kinase Pim-3 in
RT   hepatocellular carcinoma development and its role in the proliferation
RT   of human hepatoma cell lines.";
RL   Int. J. Cancer 114:209-218(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION FROM ESTS.
RX   PubMed=12798037; DOI=10.1016/S1476-9271(02)00095-6;
RA   Chichester C., Nikitin F., Ravarini J.-C., Lisacek F.;
RT   "Consistency checks for characterizing protein forms.";
RL   Comput. Biol. Chem. 27:29-35(2003).
RN   [6]
RP   INTERACTION WITH PPP2CA, PHOSPHORYLATION, AND UBIQUITINATION.
RX   PubMed=12473674; DOI=10.1074/jbc.M208246200;
RA   Losman J.A., Chen X.P., Vuong B.Q., Fay S., Rothman P.B.;
RT   "Protein phosphatase 2A regulates the stability of Pim protein
RT   kinases.";
RL   J. Biol. Chem. 278:4800-4805(2003).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF BAD, AND TISSUE SPECIFICITY.
RX   PubMed=16818649; DOI=10.1158/0008-5472.CAN-05-4272;
RA   Li Y.Y., Popivanova B.K., Nagai Y., Ishikura H., Fujii C., Mukaida N.;
RT   "Pim-3, a proto-oncogene with serine/threonine kinase activity, is
RT   aberrantly expressed in human pancreatic cancer and phosphorylates bad
RT   to block bad-mediated apoptosis in human pancreatic cancer cell
RT   lines.";
RL   Cancer Res. 66:6741-6747(2006).
RN   [8]
RP   FUNCTION, INTERACTION WITH BAD, AND TISSUE SPECIFICITY.
RX   PubMed=17270021; DOI=10.1111/j.1349-7006.2007.00390.x;
RA   Popivanova B.K., Li Y.Y., Zheng H., Omura K., Fujii C., Tsuneyama K.,
RA   Mukaida N.;
RT   "Proto-oncogene, Pim-3 with serine/threonine kinase activity, is
RT   aberrantly expressed in human colon cancer cells and can prevent Bad-
RT   mediated apoptosis.";
RL   Cancer Sci. 98:321-328(2007).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF CDKN1B.
RX   PubMed=18593906; DOI=10.1158/0008-5472.CAN-08-0634;
RA   Morishita D., Katayama R., Sekimizu K., Tsuruo T., Fujita N.;
RT   "Pim kinases promote cell cycle progression by phosphorylating and
RT   down-regulating p27Kip1 at the transcriptional and posttranscriptional
RT   levels.";
RL   Cancer Res. 68:5076-5085(2008).
RN   [10]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17876606; DOI=10.1007/s00432-007-0310-1;
RA   Zheng H.C., Tsuneyama K., Takahashi H., Miwa S., Sugiyama T.,
RA   Popivanova B.K., Fujii C., Nomoto K., Mukaida N., Takano Y.;
RT   "Aberrant Pim-3 expression is involved in gastric adenoma-
RT   adenocarcinoma sequence and cancer progression.";
RL   J. Cancer Res. Clin. Oncol. 134:481-488(2008).
CC   -!- FUNCTION: Proto-oncogene with serine/threonine kinase activity
CC       that can prevent apoptosis, promote cell survival and protein
CC       translation. May contribute to tumorigenesis through: the delivery
CC       of survival signaling through phosphorylation of BAD which induces
CC       release of the anti-apoptotic protein Bcl-X(L), the regulation of
CC       cell cycle progression, protein synthesis and by regulation of MYC
CC       transcriptional activity. Additionally to this role on
CC       tumorigenesis, can also negatively regulate insulin secretion by
CC       inhibiting the activation of MAPK1/3 (ERK1/2), through SOCS6.
CC       Involved also in the control of energy metabolism and regulation
CC       of AMPK activity in modulating MYC and PPARGC1A protein levels and
CC       cell growth. {ECO:0000269|PubMed:15540201,
CC       ECO:0000269|PubMed:16818649, ECO:0000269|PubMed:17270021,
CC       ECO:0000269|PubMed:17876606, ECO:0000269|PubMed:18593906}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with BAD. Interacts with PPP2CA; this
CC       interaction promotes dephosphorylation of PIM3, ubiquitination and
CC       proteasomal degradation. Interacts with SOCS6 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17876606}.
CC   -!- TISSUE SPECIFICITY: Detected in various tissues, including the
CC       heart, brain, lung, kidney, spleen, placenta, skeletal muscle, and
CC       peripheral blood leukocytes. Not found or barely expressed in the
CC       normal adult endoderm-derived organs such as colon, thymus, liver,
CC       or small intestine. However, expression is augmented in
CC       premalignant and malignant lesions of these organs.
CC       {ECO:0000269|PubMed:15540201, ECO:0000269|PubMed:16818649,
CC       ECO:0000269|PubMed:17270021}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:12473674}.
CC   -!- PTM: Phosphorylated. Interaction with PPP2CA promotes
CC       dephosphorylation. {ECO:0000269|PubMed:12473674}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. PIM subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB114795; BAD42438.1; -; mRNA.
DR   EMBL; AK292005; BAF84694.1; -; mRNA.
DR   EMBL; CR536608; CAO03523.1; -; Genomic_DNA.
DR   EMBL; BX539320; CAO03523.1; JOINED; Genomic_DNA.
DR   EMBL; BX539320; CAO03581.1; -; Genomic_DNA.
DR   EMBL; CR536608; CAO03581.1; JOINED; Genomic_DNA.
DR   EMBL; BC052239; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC141855; AAI41856.1; -; mRNA.
DR   CCDS; CCDS33678.1; -.
DR   RefSeq; NP_001001852.2; NM_001001852.3.
DR   UniGene; Hs.530381; -.
DR   ProteinModelPortal; Q86V86; -.
DR   SMR; Q86V86; -.
DR   BioGrid; 136104; 1.
DR   IntAct; Q86V86; 2.
DR   MINT; MINT-6823599; -.
DR   STRING; 9606.ENSP00000353824; -.
DR   BindingDB; Q86V86; -.
DR   ChEMBL; CHEMBL5407; -.
DR   GuidetoPHARMACOLOGY; 2160; -.
DR   iPTMnet; Q86V86; -.
DR   PhosphoSitePlus; Q86V86; -.
DR   BioMuta; PIM3; -.
DR   DMDM; 215274221; -.
DR   MaxQB; Q86V86; -.
DR   PaxDb; Q86V86; -.
DR   PeptideAtlas; Q86V86; -.
DR   PRIDE; Q86V86; -.
DR   Ensembl; ENST00000360612; ENSP00000353824; ENSG00000198355.
DR   GeneID; 415116; -.
DR   KEGG; hsa:415116; -.
DR   UCSC; uc003bjb.4; human.
DR   CTD; 415116; -.
DR   DisGeNET; 415116; -.
DR   GeneCards; PIM3; -.
DR   H-InvDB; HIX0203204; -.
DR   HGNC; HGNC:19310; PIM3.
DR   HPA; HPA068758; -.
DR   MIM; 610580; gene.
DR   neXtProt; NX_Q86V86; -.
DR   OpenTargets; ENSG00000198355; -.
DR   PharmGKB; PA134980758; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119045; -.
DR   HOGENOM; HOG000231357; -.
DR   HOVERGEN; HBG106681; -.
DR   InParanoid; Q86V86; -.
DR   KO; K08807; -.
DR   OMA; PEWIRHR; -.
DR   OrthoDB; EOG091G0IMW; -.
DR   PhylomeDB; Q86V86; -.
DR   TreeFam; TF320810; -.
DR   SignaLink; Q86V86; -.
DR   SIGNOR; Q86V86; -.
DR   ChiTaRS; PIM3; human.
DR   GenomeRNAi; 415116; -.
DR   PRO; PR:Q86V86; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000198355; -.
DR   CleanEx; HS_PIM3; -.
DR   Genevisible; Q86V86; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017348; PIM1/2/3.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037993; STPK_Pim-1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell cycle; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    326       Serine/threonine-protein kinase pim-3.
FT                                /FTId=PRO_0000086533.
FT   DOMAIN       40    293       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      46     54       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    170    170       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      69     69       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   CONFLICT     37     37       E -> K (in Ref. 4; AAI41856).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       V -> A (in Ref. 1; BAD42438, 2; BAF84694
FT                                and 4; AAI41856). {ECO:0000305}.
SQ   SEQUENCE   326 AA;  35891 MW;  41FDEFAC4367A162 CRC64;
     MLLSKFGSLA HLCGPGGVDH LPVKILQPAK ADKESFEKAY QVGAVLGSGG FGTVYAGSRI
     ADGLPVAVKH VVKERVTEWG SLGGATVPLE VVLLRKVGAA GGARGVIRLL DWFERPDGFL
     LVLERPEPAQ DLFDFITERG ALDEPLARRF FAQVLAAVRH CHSCGVVHRD IKDENLLVDL
     RSGELKLIDF GSGALLKDTV YTDFDGTRVY SPPEWIRYHR YHGRSATVWS LGVLLYDMVC
     GDIPFEQDEE ILRGRLLFRR RVSPECQQLI RWCLSLRPSE RPSLDQIAAH PWMLGADGGV
     PESCDLRLCT LDPDDVASTT SSSESL
//
